A SINGLE-ARM, MULTI-CENTER, OBSERVATIONAL CLINICAL STUDY of SELINEXOR COMBINED BORTEZOMIB, LENALIDOMIDE, and DEXAMETHASONE REGIMEN for NEWLY DIAGNOSED MULTIPLE MYELOMA(NDMM) with HIGH-RISK FACTORS

Category Primary study
Conference30th Congress of theEuropean Hematology Association Annual Congress, EHA2025
Year 2025
This article has no abstract
Epistemonikos ID: 6942bd45ab43523b4ed658b1ee886e2a67ed8c7f
First added on: Nov 15, 2025